Yafen Liang
The University of Texas Health Science Center, Houston
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Yafen Liang as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 03:51 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT06706258 · Post-Cardiac Surgery Acute Kidney Injury Prevention by Administration of Proton Pump Inhibitor (P2 Trial)The University of Texas Health Science Center, Houston · recruiting · Acute Kidney Injury · principal investigator
- Ph2/Ph3NCT06531642 · Comparison of Early Proton Pump Inhibitor Initiation Versus Usual Care on Acute Kidney Injury in Hemorrhagic Shock PatientsThe University of Texas Health Science Center, Houston · recruiting · Acute Kidney Injury · principal investigator
- Ph2NCT06154226 · Prevention of Post-Cardiac Surgery Acute Kidney Injury by Proton Pump InhibitorThe University of Texas Health Science Center, Houston · completed · Acute Kidney Injury · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 03:51 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 03:51 UTC. The ranking covers the 200 most relevant of 566 PubMed records, and a shared surname and initials can bring in a namesake. All 566 on PubMed
- Rivaroxaban with or without Aspirin in Stable Cardiovascular Disease.N Engl J Med · 20171,826 citationsRCR 72.0
- Endovascular treatment versus standard medical treatment for vertebrobasilar artery occlusion (BEST): an open-label, randomised controlled trial.Lancet Neurol · 2020545 citationsRCR 33.6
- Lenvatinib Combined With Transarterial Chemoembolization as First-Line Treatment for Advanced Hepatocellular Carcinoma: A Phase III, Randomized Clinical Trial (LAUNCH).J Clin Oncol · 2023432 citationsRCR 47.3
- Safety of Proton Pump Inhibitors Based on a Large, Multi-Year, Randomized Trial of Patients Receiving Rivaroxaban or Aspirin.Gastroenterology · 2019398 citationsRCR 19.7
- An inactivated enterovirus 71 vaccine in healthy children.N Engl J Med · 2014329 citationsRCR 12.0
- BCMA-CD19 compound CAR T cells for systemic lupus erythematosus: a phase 1 open-label clinical trial.Ann Rheum Dis · 2024207 citationsRCR 26.0
- 188 citationsRCR 23.0
- Brachial blood pressure but not carotid arterial waveforms predict cardiovascular events in elderly female hypertensives.Hypertension · 2006147 citationsRCR 4.0
- Pantoprazole to Prevent Gastroduodenal Events in Patients Receiving Rivaroxaban and/or Aspirin in a Randomized, Double-Blind, Placebo-Controlled Trial.Gastroenterology · 2019122 citationsRCR 5.4
- Safety and Efficacy of a Typhoid Conjugate Vaccine in Malawian Children.N Engl J Med · 2021110 citationsRCR 7.4